SearchDictionaryMobileLogin

[Plasmapheresis in Guillain-Barre syndrome]

AbstractOBJECTIVE: To evaluate the efficacy of early therapeutic plasmapheresis in severely affected patients with Guillain-Barré syndrome (GBS). PATIENTS AND METHOD: Patients between 16 to 70 years of age, with GBS according to NINCDS criteria, in stage > or = 3 of Huges severity score and with less than 7 days of onset of symptoms were admitted for therapeutic plasmapheresis. All patients completed a total of five sessions of plasma exchange every other day using 25% albumin and saline in a 1:1 proportion. Follow-up was performed for 6 months. Friedman and Wilcoxon tests were done to establish differences within groups. RESULTS: A total of 34 patients were admitted to the study. The time span between onset of symptoms and admission to the study was 4 days (median). Fourteen (41%) required mechanical ventilation. Clinical progression of the syndrome was observed during the first two sessions of plasma-pheresis. Improvement in motor function by Huges score was observed only after fourth session of plasma exchange (p < 0.05). Two patients did not improve, and one died. CONCLUSIONS: Clinical improvement in GBS during early therapeutic plasmapheresis occurs only after the fourth session of plasma exchange.
AuthorsAngélica Carbajal-Ramírez, Jorge Alberto Castañón-González, Juan Osvaldo-Talavera, María Luisa de la Torre-Nieto, Marco Antonio León-Gutiérrez (Affiliation: Servicio de Neurología, Dr. Bernardo Sepúlveda G. del Centro Médico Nacional Siglo XXI, IMSS, México, D.F.)
JournalGaceta médica de México (Gac Med Mex) 2002 Nov-Dec Vol. 138 Issue 6 Pg. 527-31 ISSN: 0016-3813 Mexico
Vernacular TitlePlasmaféresis en el síndrome de Guillain-Barré.
PMID12532617 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Female
  • Guillain-Barre Syndrome (therapy)
  • Humans
  • Male
  • Middle Aged
  • Plasmapheresis